Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases. |
別名 | Tofacitinib metabolite M2, CP-690,550A, UNII-Q7ZOK859UK |
分子量 | 303.36 |
分子式 | C15H21N5O2 |
CAS No. | 1243290-37-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CP-690550A 1243290-37-0 CP690550A Tofacitinib metabolite M2 CP 690550A CP-690,550A UNII-Q7ZOK859UK Inhibitor inhibitor inhibit